Electronegative LDL from normolipemic subjects induces IL-8 and monocyte chemotactic protein secretion by human endothelial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 10, 2000, Pages 2281-2287

  De Castellarnau, Conxita ^a,c   Sánchez Quesada, José Luis ^a   Benítez, Sonia ^a,b   Rosa, Roser ^a   Caveda, Luis ^a   Vila, Luis ^a   Ordóñez Llanos, Jordi ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c NONE   (Spain)

Author keywords

Electronegative LDL; Endothelial cells; Interleukin 8; LDL; Monocyte chemotactic protein

Indexed keywords

6 (2 CHLOROPHENYL) 4,7,8,10 TETRAHYDRO 9 (4 METHOXYPHENYLCARBAMOYL) 1 METHYLPYRIDO[4',3'; ACETYLCYSTEINE; ANTIOXIDANT; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; BUTYLCRESOL; CHEMOKINE; FATTY ACID; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SIALIC ACID; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATHEROSCLEROSIS; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LIPID OXIDATION; MALE; PRIORITY JOURNAL; PROTEIN SECRETION;

EID: 0033786167     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.atv.20.10.2281     Document Type: Article

References (48)

1. Oxidative modification of LDL and atherogenesis
2. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesion of rabbit and man
3. Autoantibody against oxidised LDL and progression of carotid atherosclerosis
4. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease
5. The yin and yang of oxidation in the development of the fatty streak: A review based on the 1994 George Lyman Duff memorial lecture
6. Chemokines and atherosclerosis
7. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions
8. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells
9. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein l synthesis and is abolished by high density lipoprotein
10. Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity
11. Oxidized low-density lipoprotein induces the production of interleukin-8 by endothelial cells
12. Cytokine regulation of endothelial cell function
13. Oxidized lipoproteins in atherosclerosis and thrombosis
14. Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs: An LDL receptor-independent phenomenon
15. Presence of a modified low density lipoprotein in humans
16. Characterization of a more electronegatively charged LDL subfraction by ion exchange HPLC
17. Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-)
18. LDL - is a lipid hydroperoxide-enriched circulating lipoprotein
19. Contribution of an in vivo oxidized LDL to LDL oxidation and its association with dense LDL subpopulations
20. Oxidation-labile subfraction of human plasma low density lipoprotein isolated by anion-exchange chromatography
21. A cytotoxic LDL(-) subfraction is present in human plasma
22. Characteristics of ten charge-differing subfractions isolated from human native low-density lipoproteins (LDL): No evidence of peroxidative modifications
23. Fractionation of charge-modified low density lipoproteins by fast protein liquid chromatography
24. Effect of simvastatin treatment on the electronegative low-density lipoprotein present in patients with heterozygous familial hypercholesterolemia
25. Electronegative low density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic control
26. Characterization and determinants of an electronegatively charged low-density lipoprotein in human plasma
27. Platelet LDL receptor recognizes with the same apparent affinity both oxidized and native LDL: Evidence that the receptor-ligand complexes are not internalized
28. Determination of sialic acids in human serum by reversed-phase liquid chromatography with fluorimetric detection
29. Simultaneous measurement of serum probucol and lipid-soluble antioxidants
30. LDL from aerobically-trained subjects shows higher resistance to oxidative modification than LDL from sedentary subjects
31. Ascorbic acid inhibits the increase in low-density lipoprotein (LDL) susceptibility to oxidation and the proportion of LDL(-) induced by intense aerobic exercise
32. Continuous monitoring of in vitro oxidation of human low density lipoprotein
33. Interleukin-1 increases 15-hydroxyeicosatetraenoic acid formation in cultured human endothelial cells
34. Effects of linoleic and oleic acid anilides on prostacyclin synthesis and fibrinolytic profile of human endothelial cells in culture: Relevance to the toxic oil syndrome
35. Effect of platelet-activating factor on platelets and vascular endothelium
36. Use of tetrazolium assay in measuring the response of human tumor cell to ionizing radiations
37. Cytotoxicity of hexachlorocyclohexane isomers and cyclodienes in primary cultures of cerebellar granule cells
38. Toxicity of oxygenated cholesterol derivatives toward cultured human umbilical vein endothelial cells
39. Plasma triglycerides determine low density lipoprotein composition, physical properties and cell-specific binding in cultured cells
40. Interaction of low density lipoproteins with arterial proteoglycans: The role of charge and sialic acid content
41. The effect of free fatty acids on the migration rates of lipoproteins in paper electrophoresis
42. All apoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified: Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase
43. Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8 and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: Modulation of NF-κB and AP-1 transcription factor activity
44. Effects of N-acetylcysteine in the rat heart reperfused after low-flow ischemia: Evidence for a direct scavenging of hydroxyl radicals and a nitric oxide-dependent increase in coronary flow
45. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo
46. The nuclear factor-kappaB/inhibitor of kappa B autoregulatory system and atherosclerosis
47. Interaction of AP-1-, AP-2-, and SP1-like proteins with two distinct sites in the upstream regulatory region of the plasminogen activator inhibitor-1 gene mediates the phorbol 12-myristate 13-acetate response
48. Linoleic acid activates nuclear transcription factor-kappaB (NF-kappaB) and induces NF-kappaB-dependent transcription in cultured endothelial cells